Clinical Endocrinology · Published 2026-08-03 · DOI 10.1111/cen.70184
Annabelle M. Warren, Kay Weng Choy, Rudolf Hoermann, Nicholas Russell, Mathis Grossmann
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Warren, A., Choy, K., Hoermann, R., et al. (2026). Serum Copeptin Rises After Tolvaptan for Hyponatraemia, but Does Not Predict Risk of Rapid Sodium Rise: Pre‐Specified Secondary Analysis of the TVFR Trial. Clinical Endocrinology. https://doi.org/10.1111/cen.70184